Not only the targeting of specific antibodies against AMHR2 in tumor tissue should be considered in future oncotherapy, as the anti-proliferative activity of AMH manifests in two aspects the influence on the cell cycle and the regulation of apoptosis. The gene discussed is AMH; the disease is neoplasm.